Traveler's Diarrhea Therapeutics Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
SUMMARY
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Traveler's Diarrhea Therapeutics market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Traveler's Diarrhea Therapeutics market segmented into
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Traveler's Diarrhea Therapeutics market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Traveler's Diarrhea Therapeutics market segmented into
- Anti-Motility Agents
- Bismuth Subsalicylate (Pepto-Bismol)
- Antibiotics
- Adult Traveler's Diarrhea
- Children Traveler's Diarrhea
- North America [U.S., Canada, Mexico]
- Europe [Germany, UK, France, Italy, Rest of Europe]
- Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
- South America [Brazil, Argentina, Rest of Latin America]
- Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
- GSK
- Salix Pharmaceuticals
- Chiesi Farmaceutici
- Cosmo Pharmaceuticals
- Nippon Shinyaku
- Prokarium Limited
- Scandinavian Biopharma
- Sigmoid Pharma
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL TRAVELER'S DIARRHEA THERAPEUTICS INDUSTRY
2.1 Summary about Traveler's Diarrhea Therapeutics Industry
2.2 Traveler's Diarrhea Therapeutics Market Trends
2.2.1 Traveler's Diarrhea Therapeutics Production & Consumption Trends
2.2.2 Traveler's Diarrhea Therapeutics Demand Structure Trends
2.3 Traveler's Diarrhea Therapeutics Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Anti-Motility Agents
4.2.2 Bismuth Subsalicylate (Pepto-Bismol)
4.2.3 Antibiotics
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Adult Traveler's Diarrhea
4.3.2 Children Traveler's Diarrhea
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Anti-Motility Agents
5.2.2 Bismuth Subsalicylate (Pepto-Bismol)
5.2.3 Antibiotics
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Adult Traveler's Diarrhea
5.3.2 Children Traveler's Diarrhea
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Anti-Motility Agents
6.2.2 Bismuth Subsalicylate (Pepto-Bismol)
6.2.3 Antibiotics
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Adult Traveler's Diarrhea
6.3.2 Children Traveler's Diarrhea
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Anti-Motility Agents
7.2.2 Bismuth Subsalicylate (Pepto-Bismol)
7.2.3 Antibiotics
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Adult Traveler's Diarrhea
7.3.2 Children Traveler's Diarrhea
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Anti-Motility Agents
8.2.2 Bismuth Subsalicylate (Pepto-Bismol)
8.2.3 Antibiotics
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Adult Traveler's Diarrhea
8.3.2 Children Traveler's Diarrhea
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Anti-Motility Agents
9.2.2 Bismuth Subsalicylate (Pepto-Bismol)
9.2.3 Antibiotics
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Adult Traveler's Diarrhea
9.3.2 Children Traveler's Diarrhea
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 GSK
10.1.2 Salix Pharmaceuticals
10.1.3 Chiesi Farmaceutici
10.1.4 Cosmo Pharmaceuticals
10.1.5 Nippon Shinyaku
10.1.6 Prokarium Limited
10.1.7 Scandinavian Biopharma
10.1.8 Sigmoid Pharma
10.2 Traveler's Diarrhea Therapeutics Sales Date of Major Players (2017-2020e)
10.2.1 GSK
10.2.2 Salix Pharmaceuticals
10.2.3 Chiesi Farmaceutici
10.2.4 Cosmo Pharmaceuticals
10.2.5 Nippon Shinyaku
10.2.6 Prokarium Limited
10.2.7 Scandinavian Biopharma
10.2.8 Sigmoid Pharma
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL TRAVELER'S DIARRHEA THERAPEUTICS INDUSTRY
2.1 Summary about Traveler's Diarrhea Therapeutics Industry
2.2 Traveler's Diarrhea Therapeutics Market Trends
2.2.1 Traveler's Diarrhea Therapeutics Production & Consumption Trends
2.2.2 Traveler's Diarrhea Therapeutics Demand Structure Trends
2.3 Traveler's Diarrhea Therapeutics Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Anti-Motility Agents
4.2.2 Bismuth Subsalicylate (Pepto-Bismol)
4.2.3 Antibiotics
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Adult Traveler's Diarrhea
4.3.2 Children Traveler's Diarrhea
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Anti-Motility Agents
5.2.2 Bismuth Subsalicylate (Pepto-Bismol)
5.2.3 Antibiotics
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Adult Traveler's Diarrhea
5.3.2 Children Traveler's Diarrhea
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Anti-Motility Agents
6.2.2 Bismuth Subsalicylate (Pepto-Bismol)
6.2.3 Antibiotics
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Adult Traveler's Diarrhea
6.3.2 Children Traveler's Diarrhea
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Anti-Motility Agents
7.2.2 Bismuth Subsalicylate (Pepto-Bismol)
7.2.3 Antibiotics
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Adult Traveler's Diarrhea
7.3.2 Children Traveler's Diarrhea
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Anti-Motility Agents
8.2.2 Bismuth Subsalicylate (Pepto-Bismol)
8.2.3 Antibiotics
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Adult Traveler's Diarrhea
8.3.2 Children Traveler's Diarrhea
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Anti-Motility Agents
9.2.2 Bismuth Subsalicylate (Pepto-Bismol)
9.2.3 Antibiotics
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Adult Traveler's Diarrhea
9.3.2 Children Traveler's Diarrhea
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 GSK
10.1.2 Salix Pharmaceuticals
10.1.3 Chiesi Farmaceutici
10.1.4 Cosmo Pharmaceuticals
10.1.5 Nippon Shinyaku
10.1.6 Prokarium Limited
10.1.7 Scandinavian Biopharma
10.1.8 Sigmoid Pharma
10.2 Traveler's Diarrhea Therapeutics Sales Date of Major Players (2017-2020e)
10.2.1 GSK
10.2.2 Salix Pharmaceuticals
10.2.3 Chiesi Farmaceutici
10.2.4 Cosmo Pharmaceuticals
10.2.5 Nippon Shinyaku
10.2.6 Prokarium Limited
10.2.7 Scandinavian Biopharma
10.2.8 Sigmoid Pharma
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
LIST OF TABLES
1.Table Traveler's Diarrhea Therapeutics Product Type Overview
2.Table Traveler's Diarrhea Therapeutics Product Type Market Share List
3.Table Traveler's Diarrhea Therapeutics Product Type of Major Players
4.Table Brief Introduction of GSK
5.Table Brief Introduction of Salix Pharmaceuticals
6.Table Brief Introduction of Chiesi Farmaceutici
7.Table Brief Introduction of Cosmo Pharmaceuticals
8.Table Brief Introduction of Nippon Shinyaku
9.Table Brief Introduction of Prokarium Limited
10.Table Brief Introduction of Scandinavian Biopharma
11.Table Brief Introduction of Sigmoid Pharma
12.Table Products & Services of GSK
13.Table Products & Services of Salix Pharmaceuticals
14.Table Products & Services of Chiesi Farmaceutici
15.Table Products & Services of Cosmo Pharmaceuticals
16.Table Products & Services of Nippon Shinyaku
17.Table Products & Services of Prokarium Limited
18.Table Products & Services of Scandinavian Biopharma
19.Table Products & Services of Sigmoid Pharma
20.Table Market Distribution of Major Players
21.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
22.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
23.Table Global Traveler's Diarrhea Therapeutics Market Forecast (Million USD) by Region 2021f-2026f
24.Table Global Traveler's Diarrhea Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f
25.Table Global Traveler's Diarrhea Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f
26.Table Global Traveler's Diarrhea Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f
1.Table Traveler's Diarrhea Therapeutics Product Type Overview
2.Table Traveler's Diarrhea Therapeutics Product Type Market Share List
3.Table Traveler's Diarrhea Therapeutics Product Type of Major Players
4.Table Brief Introduction of GSK
5.Table Brief Introduction of Salix Pharmaceuticals
6.Table Brief Introduction of Chiesi Farmaceutici
7.Table Brief Introduction of Cosmo Pharmaceuticals
8.Table Brief Introduction of Nippon Shinyaku
9.Table Brief Introduction of Prokarium Limited
10.Table Brief Introduction of Scandinavian Biopharma
11.Table Brief Introduction of Sigmoid Pharma
12.Table Products & Services of GSK
13.Table Products & Services of Salix Pharmaceuticals
14.Table Products & Services of Chiesi Farmaceutici
15.Table Products & Services of Cosmo Pharmaceuticals
16.Table Products & Services of Nippon Shinyaku
17.Table Products & Services of Prokarium Limited
18.Table Products & Services of Scandinavian Biopharma
19.Table Products & Services of Sigmoid Pharma
20.Table Market Distribution of Major Players
21.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
22.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
23.Table Global Traveler's Diarrhea Therapeutics Market Forecast (Million USD) by Region 2021f-2026f
24.Table Global Traveler's Diarrhea Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f
25.Table Global Traveler's Diarrhea Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f
26.Table Global Traveler's Diarrhea Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
1.Figure Global Traveler's Diarrhea Therapeutics Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Traveler's Diarrhea Therapeutics Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Traveler's Diarrhea Therapeutics Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Traveler's Diarrhea Therapeutics Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Traveler's Diarrhea Therapeutics Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Traveler's Diarrhea Therapeutics Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Traveler's Diarrhea Therapeutics Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Anti-Motility Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Bismuth Subsalicylate (Pepto-Bismol) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Adult Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Children Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Anti-Motility Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Bismuth Subsalicylate (Pepto-Bismol) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Adult Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Children Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Anti-Motility Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Bismuth Subsalicylate (Pepto-Bismol) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Adult Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Children Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Anti-Motility Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Bismuth Subsalicylate (Pepto-Bismol) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Adult Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Children Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Anti-Motility Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Bismuth Subsalicylate (Pepto-Bismol) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Adult Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Children Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Anti-Motility Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Bismuth Subsalicylate (Pepto-Bismol) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Adult Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Children Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Traveler's Diarrhea Therapeutics Sales Revenue (Million USD) of GSK 2017-2020e
66.Figure Traveler's Diarrhea Therapeutics Sales Revenue (Million USD) of Salix Pharmaceuticals 2017-2020e
67.Figure Traveler's Diarrhea Therapeutics Sales Revenue (Million USD) of Chiesi Farmaceutici 2017-2020e
68.Figure Traveler's Diarrhea Therapeutics Sales Revenue (Million USD) of Cosmo Pharmaceuticals 2017-2020e
69.Figure Traveler's Diarrhea Therapeutics Sales Revenue (Million USD) of Nippon Shinyaku 2017-2020e
70.Figure Traveler's Diarrhea Therapeutics Sales Revenue (Million USD) of Prokarium Limited 2017-2020e
71.Figure Traveler's Diarrhea Therapeutics Sales Revenue (Million USD) of Scandinavian Biopharma 2017-2020e
72.Figure Traveler's Diarrhea Therapeutics Sales R
1.Figure Global Traveler's Diarrhea Therapeutics Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Traveler's Diarrhea Therapeutics Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Traveler's Diarrhea Therapeutics Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Traveler's Diarrhea Therapeutics Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Traveler's Diarrhea Therapeutics Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Traveler's Diarrhea Therapeutics Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Traveler's Diarrhea Therapeutics Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Anti-Motility Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Bismuth Subsalicylate (Pepto-Bismol) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Adult Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Children Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Anti-Motility Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Bismuth Subsalicylate (Pepto-Bismol) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Adult Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Children Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Anti-Motility Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Bismuth Subsalicylate (Pepto-Bismol) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Adult Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Children Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Anti-Motility Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Bismuth Subsalicylate (Pepto-Bismol) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Adult Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Children Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Anti-Motility Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Bismuth Subsalicylate (Pepto-Bismol) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Adult Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Children Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Anti-Motility Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Bismuth Subsalicylate (Pepto-Bismol) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Adult Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Children Traveler's Diarrhea Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Traveler's Diarrhea Therapeutics Sales Revenue (Million USD) of GSK 2017-2020e
66.Figure Traveler's Diarrhea Therapeutics Sales Revenue (Million USD) of Salix Pharmaceuticals 2017-2020e
67.Figure Traveler's Diarrhea Therapeutics Sales Revenue (Million USD) of Chiesi Farmaceutici 2017-2020e
68.Figure Traveler's Diarrhea Therapeutics Sales Revenue (Million USD) of Cosmo Pharmaceuticals 2017-2020e
69.Figure Traveler's Diarrhea Therapeutics Sales Revenue (Million USD) of Nippon Shinyaku 2017-2020e
70.Figure Traveler's Diarrhea Therapeutics Sales Revenue (Million USD) of Prokarium Limited 2017-2020e
71.Figure Traveler's Diarrhea Therapeutics Sales Revenue (Million USD) of Scandinavian Biopharma 2017-2020e
72.Figure Traveler's Diarrhea Therapeutics Sales R
